Azitra (AZTR) Cash from Financing Activities (2022 - 2026)

Azitra (AZTR) reported Cash from Financing Activities of $10.5 million for Q1 2026, up 501.42% on a YoY basis from $1.7 million in Q1 2025, and up 188.18% quarter-over-quarter from $3.6 million in Q4 2025.

Azitra (AZTR) Cash from Financing Activities (2022 - 2026) Analysis & Trends

Azitra has reported Cash from Financing Activities for 5 years, with the latest figure at $10.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 501.42% year-over-year to $10.5 million; the trailing twelve-month figure through Mar 2026 stood at $17.7 million (up 64.23% YoY), and the FY2025 full-year result was $8.9 million, down 33.04% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $10.5 million, up from $3.6 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $10.5 million in Q1 2026, with the low at -$272080.0 in Q1 2023.
  • Historically, Cash from Financing Activities has averaged $2.9 million across 5 years, with a median of $1.7 million in 2025.
  • The largest YoY upside for Cash from Financing Activities was 402621.1% in 2024 against a maximum downside of 100.34% in 2024.
  • Azitra's Cash from Financing Activities stood at -$176183.0 in 2022, then surged by 97.08% to -$5146.0 in 2023, then increased by 26.51% to -$3782.0 in 2024, then surged by 96416.08% to $3.6 million in 2025, then surged by 188.18% to $10.5 million in 2026.
  • The last three Cash from Financing Activities figures came in at $10.5 million (Q1 2026), $3.6 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Azitra 20,900.00 20,900.00 - 10.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.50 Mn
Mar 31, 2026 10.50 Mn
Dec 31, 2025 3.64 Mn
Dec 31, 2025 3.64 Mn
Sep 30, 2025 2.84 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 690,343.00
Jun 30, 2025 690,343.00
Mar 31, 2025 1.75 Mn
Mar 31, 2025 1.75 Mn
Dec 31, 2024 -3,782.00
Dec 31, 2024 -3,782.00
Sep 30, 2024 9.04 Mn
Sep 30, 2024 9.04 Mn
Jun 30, 2024 -21,381.00
Jun 30, 2024 -21,381.00
Mar 31, 2024 4.31 Mn
Mar 31, 2024 4.31 Mn
Dec 31, 2023 -5,146.00
Dec 31, 2023 -5,146.00